logo
ResearchBunny Logo
Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

Medicine and Health

Effectiveness of BA.1-and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

T. Arashiro, Y. Arima, et al.

In a groundbreaking study conducted in Japan, researchers including Takeshi Arashiro and Yuzo Arima found that both BA.1-containing and BA.4/BA.5-containing bivalent mRNA vaccines showed high effectiveness against symptomatic COVID-19 infection during the BA.5-dominant period, outperforming monovalent vaccines and providing significant protection.

00:00
00:00
Playback language: English
Citation Metrics
Citations
0
Influential Citations
0
Reference Count
0

Note: The citation metrics presented here have been sourced from Semantic Scholar and OpenAlex.

Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny